Related Experiment Video
Updated: Oct 30, 2025
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
380
MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
Hyuk Moon1, Simon Weonsang Ro1
1Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Korea.
Cancers
|July 2, 2021
Summary
Hepatocellular carcinoma (HCC) involves the MAPK/ERK pathway, often activated through mechanisms beyond typical RAS/RAF mutations. This review explores HCC
Area of Science:
- Oncology
- Molecular Biology
- Signaling Pathways
Background:
- Hepatocellular carcinoma (HCC) is a global health issue with rising incidence.
- The MAPK/ERK signaling pathway is frequently activated in HCC.
- RAS and RAF gene mutations, common activators in other cancers, are rare in HCC, suggesting alternative activation mechanisms.
Purpose of the Study:
- To review recent advances in understanding MAPK/ERK pathway activation in HCC.
- To discuss the cellular and molecular mechanisms driving this activation.
- To explore potential therapeutic strategies targeting the MAPK/ERK pathway in HCC.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of cellular and molecular mechanisms of MAPK/ERK pathway activation.
- Synthesis of information on therapeutic strategies.
Main Results:
- The MAPK/ERK pathway is activated in over 50% of HCC cases.
- Alternative mechanisms, not solely RAS/RAF mutations, are responsible for MAPK/ERK activation in HCC.
- Understanding these mechanisms is crucial for developing targeted therapies.
Conclusions:
- The MAPK/ERK pathway plays a significant role in HCC pathogenesis.
- Identifying non-canonical activation routes is key for effective treatment.
- Targeting the MAPK/ERK pathway offers promising therapeutic avenues for HCC.
Related Concept Videos
01:07MAPK Signaling Cascades
6.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.7K
01:19Interactions Between Signaling Pathways
6.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
01:22PI3K/mTOR/AKT Signaling Pathway
4.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.3K
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K
02:38Mitogens and the Cell Cycle
7.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
01:22Amplifying Signals via Enzymatic Cascade
14.6K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.6K